Making opioid treatment measurable for health plans

We help health plans improve opioid treatment through greater accountability, expanded access, and actionable data — aligning incentives to deliver higher-quality, evidence-based care.

The opioid crisis calls for thoughtful leadership

Methadone treatment has changed little in 30+ years, even as the opioid crisis, regulations, and healthcare costs have evolved. With roughly 70% of methadone patients covered by Medicaid, health plans have a unique opportunity to improve outcomes while reducing costs.

The current landscape

  • Up to half of all NEMT spend is for OTP patients

    In-person dosing requirements and variable take-home schedules drive unnecessarily high transportation utilization.

  • Treatment abandonment fuels costly care

    More than 50% of patients drop out within 60 days, increasing avoidable ED visits and inpatient utilization. 

  • Today’s provider incentives drive billing volume, not treatment quality

    Without standardized performance data, plans cannot effectively incentivize higher-quality care or reduce costs tied to ED utilization, NEMT, and avoidable admissions. 

  • Missed quality measures

    Limited adherence tracking creates follow-up gaps that impact HEDIS and Star Ratings. 

How Sonara helps health plans

Greater transparency into dosing, engagement, and outcomes creates the opportunity to strengthen performance and ensure opioid treatment investments deliver measurable value.

  • Increase access

    Patients receive nearly twice as many take-home doses after enrolling with Sonara, reducing the burden of treatment while maintaining accountability.

  • Reduce avoidable utilization

    Support responsible take-home expansion while decreasing unnecessary NEMT and preventable acute care. Sonara has demonstrated 23 fewer rides per member per month through accountable hybrid care.

  • Improve retention and adherence

    Daily engagement helps keep members connected to care, resulting in 74% adherence to care plans.

  • Strengthen quality performance

    Transparent reporting supports adherence tracking, continuity of care, and quality performance.

  • Mitigate FWA risk

    Secure verification, dose tracking, and real-time documentation create a clear audit trail. 

In-year results for health plans

Designed to deliver measurable impact within the same performance year:

  • 23 fewer NEMT rides PMPM

  • 74% adherence to care plans

  • Typical savings of $200-$400 PMPM

  • Shared savings model beginning at 3:1 ROI

  • High member satisfaction (NPS)

Verified adherence. Transparent reporting. Demonstrated value.

Let’s work together

Strengthen opioid treatment accountability. Improve outcomes. Deliver measurable value.